No Prescription |
 |
 | ||
|
Gliben Daonil |
|
| ||
No Prescription » Prescription Drugs 8 » Gliben Daonil GLIBEN tablets contain the active ingredient glibenclamide. It belongs to a group of medicines that act on the pancreas to stimulate insulin release. GLIBEN is used to treat non-insulin dependent type II diabetes when diet is not adequate. How much to takeYour doctor will tell you how much GLIBEN you need to take each day. It is important that you take GLIBEN as directed by your doctor. Do not take more than the recommended dose. The usual starting dose in adults including the elderly is: One GLIBEN tablet (2.5mg) a day before breakfast. Your doctor may raise the dose of GLIBEN by one tablet at a time (2.5mg) until your diabetes is stabilized. When you are taking 2 or more GLIBEN 2.5mg tablets your doctor may change you to GLIBEN 5mg tablets. GLIBEN is not recommended for use in children. How long to take itGLIBEN helps to control your condition but does not cure it. Therefore GLIBEN must be taken everyday. Continue taking GLIBEN for as long as your doctor tells you to. If you forget a doseIf you forget a dose just take the next dose when it is due. Do not take more than one dose at a time to make up for missed doses. Taking your medicine at the same time each day may help you to remember to take it regularly. If you have trouble remembering to take your medicine ask you pharmacist for some hints. Buy Gliben Daonil and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About Gliben Daonil: Product Type: Prescription Drugs 8 Gliben ( Daonil Generic Glibenclamide ) Gliben (Daonil Generic Glibenclamide) Daonil Generic Glibenclamide 5mg 200(2 x 100) Tablets 5mg 400(4 x 100) Tablets 5mg 100 Tablets 2.5mg 400(4 x 100) Tablets 2.5mg 200 Tablets 2.5mg 100 Tablets Daonil Generic Glibenclamide Gliben
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
